The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply. The company makes compounded versions of ...

Hims & Hers Health, Inc. (NYSE:HIMS) announced the acquisition of a California-based peptide facility to enhance its domestic ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.

Hims & Hers Health, Inc. stock surged 1,000% with strategic growth, but high valuation & short interest suggest taking ...

On Sunday, Hims & Hers Health will have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the game’s host, Fox, from broadcasting it. Why?

Investing.com -- Shares of Hims and Hers (NYSE:HIMS) climbed 5% despite facing criticism over a Super Bowl advertisement for its generic weight-loss drugs. The ad, which highlights the company's more ...

Actor Eugene Levy’s eyebrows fly off and fly around after he tries the pizza chain ... other in an effort to combat hate speech. Hims and Hers First-time advertiser Telehealth company Hims ...

Hims is part of Hims & Hers Health, a publicly-traded company (NYSE: HIMS) founded in 2017. The company solves male health problems via Hims.com and solves female health problems via ForHers.com.

Fortunately, online telehealth services like Hims and ... information before prescribing a suitable medication. This personalized approach instills confidence in users, knowing that their treatment ...